enVVeno Medical Corp (NVNO)
3.24
-1.26
(-28.00%)
USD |
NASDAQ |
Sep 27, 16:00
3.39
+0.15
(+4.63%)
After-Hours: 20:00
enVVeno Medical Research and Development Expense (Annual): 13.58M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.58M |
| December 31, 2022 | 9.914M |
| December 31, 2021 | 5.728M |
| December 31, 2020 | 4.252M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.206M |
| December 31, 2018 | 1.239M |
| December 31, 2017 | 0.6497M |
| December 31, 2016 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
2.206M
Minimum
2019
13.58M
Maximum
2023
7.137M
Average
5.728M
Median
2021
Research and Development Expense (Annual) Benchmarks
| NeuroOne Medical Technologies Corp | 6.941M |
| SINTX Technologies Inc | 8.713M |
| Nutriband Inc | 1.960M |
| Beyond Air Inc | 24.36M |
| CVRx Inc | 11.63M |